{
  "id": "SCR-LIP-000608",
  "statement": "No objective diagnostic tool or biomarker for lipedema is yet standardised or validated for routine clinical use.",
  "claim_type": "clinical_association",
  "context": {
    "population": "women with lipedema across 20 studies",
    "condition": "lipedema",
    "exposure": "imaging and measurement tools for lipedema quantification",
    "comparator": "—",
    "outcome": "consistency and clinimetric validity of assessment tools",
    "scope": "auto-ingested from Layer 1 surveillance"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "moderate",
  "evidence": [
    {
      "ref": "DOI:10.1089/lrb.2024.0102",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2025,
      "amato_authored": false,
      "note": "This systematic review directly addresses the availability and quality of screening/assessment tools for lipedema, supporting the premise that standardized screening tools are lacking (consistent with underdiagnosis), while refining the que",
      "title": "Assessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review",
      "authors": "Eason et al.",
      "journal": "Lymphatic Research and Biology",
      "grade": "moderate",
      "_prov": {
        "grade_source": "design_cap"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "The article is a systematic review of 20 studies using 13 different tools, finding lack of consistency in protocols, measurement locations, and outcome analysis, with limited clinimetric reporting from small heterogeneous cohorts — all dire",
        "date": "2026-06-10"
      },
      "quote": "Amato 2021 (ultrassom): único a propor pontos de corte diagnósticos (espessura pretibial >11,8 mm) — referência metodológica importante",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "Systematic review of assessment tools: inconsistent protocols, measurement sites and analysis with limited clinimetric reporting; only one ultrasound study proposed diagnostic cutoffs (pretibial >11.8 mm).",
      "from_claims": [
        "SCR-LIP-000067"
      ]
    },
    {
      "ref": "DOI:10.1111/obr.13648",
      "stance": "supporting",
      "study_design": "meta_analysis",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2024,
      "amato_authored": false,
      "note": "This systematic review directly addresses diagnostic tools for lipedema, supporting the notion that diagnosis is challenging (consistent with underdiagnosis) while refining the question by detailing specific imaging features and their limit",
      "title": "Diagnostic imaging in lipedema: A systematic review",
      "authors": "van la Parra et al.",
      "journal": "Obesity Reviews",
      "grade": "low",
      "grade_source": "cleanup_default",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": false,
        "verifier_stance": "refines",
        "verdict": "verified",
        "reason": "Human review: statement rewritten — specific '20 studies/13 tools' matched neither source; replaced with the qualitative finding (multiple modalities, inconsistency, no single recommended tool).",
        "date": "2026-06-10",
        "reviewed_by": "Amato (ORCID 0000-0003-4008-4029)",
        "reviewed_date": "2026-06-12"
      },
      "quote": "Diagnosing lipedema remains a challenge due to its heterogeneous presentation, co-existing diseases, and the lack of objective diagnostic imaging.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "refines",
      "finding": "Systematic review of diagnostic imaging: diagnosis remains challenging due to heterogeneous presentation, co-existing disease and lack of objective diagnostic imaging; no single modality recommended.",
      "from_claims": [
        "SCR-LIP-000067"
      ]
    },
    {
      "ref": "DOI:10.3238/arztebl.2020.0396",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "year": 2020,
      "amato_authored": false,
      "note": "This selective literature review directly addresses underdiagnosis of lipedema and the absence of objective screening/diagnostic tools, supporting the affirmative direction of the question, though it does not evaluate a specific screening t",
      "title": "Lipedema—Pathogenesis, Diagnosis, and Treatment Options",
      "authors": "Kruppa et al.",
      "journal": "Deutsches Ärzteblatt international",
      "grade": "very_low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly states lipedema is 'often unrecognized or misdiagnosed,' cites ~10% prevalence in the female population, confirms diagnosis is made on clinical grounds alone with no specific biomarker, and notes the lack of objective",
        "date": "2026-06-10"
      },
      "quote": "O diagnóstico do lipedema permanece desafiador devido à apresentação heterogênea e à ausência de instrumentos objetivos de caracterização.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "Review: diagnosis relies on clinical grounds alone owing to the lack of specific biomarkers or objective measuring instruments, despite estimated prevalence of 10%.",
      "from_claims": [
        "SCR-LIP-000069"
      ]
    },
    {
      "ref": "DOI:10.1002/jmri.28400",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2023,
      "amato_authored": false,
      "note": "Editorial commentary discussing the need for diagnostic biomarkers and a potential MR imaging tool for identifying lipedema, which contextually relates to underdiagnosis and detection/screening, but it is not a primary study quantifying und",
      "title": "Editorial for “Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T Magnetic Resonance Lymphangiography”",
      "authors": "Wang",
      "journal": "Journal of Magnetic Resonance Imaging",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "context",
        "verdict": "verified",
        "reason": "The editorial directly emphasizes the lack of reliable lipedema biomarkers, describes noncontrast 3T MR lymphangiography as a promising imaging biomarker for differential diagnosis between lipedema and obesity, and notes small sample sizes ",
        "date": "2026-06-10"
      },
      "quote": "O editorial enfatiza a carência de biomarcadores confiáveis e eficazes do lipedema e o papel potencial das medidas de RM do conteúdo de gordura tecidual no diagnóstico diferencial entre lipedema e obesidade.",
      "extraction_confidence": "high",
      "stance_in_source_claim": "context",
      "finding": "Editorial stresses the lack of reliable lipedema biomarkers and highlights 3T MR lymphangiography as a promising but small-sample imaging biomarker versus obesity.",
      "from_claims": [
        "SCR-LIP-000279"
      ]
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000067",
    "SCR-LIP-000069",
    "SCR-LIP-000279"
  ],
  "questions_consolidated": [
    "SQ-LIP-000004"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00034",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000004"
    }
  ],
  "statement_pt": "Nenhuma ferramenta diagnóstica objetiva ou biomarcador para lipedema está ainda padronizado ou validado para uso clínico de rotina.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000004",
      "role": "refines",
      "question": "Is lipedema underdiagnosed, and can screening tools help identify it?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000004.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000608.html"
}